Table 1.
UC N=379 |
LS N=316 |
P-Value* | |
---|---|---|---|
| |||
N(%) or Mean/SD | N(%) or Mean/SD | ||
| |||
Age (y) | 55.3/12.1 | 53.3/13.6 | 0.05 |
English-speaking | 261 (68.9%) | 261 (82.6%) | <0.001 |
Male | 251 (66.2%) | 163 (53.5%) | 0.001 |
Race | <0.001 | ||
White | 301 (79.4%) | 262 (82.9%) | |
Black | 31 (8.2%) | 40 (12.7%) | |
Asian | 16 (4.2%) | 0 (0.0%) | |
Other | 31 (8.2%) | 14 (4.4%) | |
Comorbidities | |||
Substance Abuse | 75 (19.8%) | 58 (18.4%) | 0.70 |
Psychiatric | 123 (32.5%) | 103 (32.9%) | 0.94 |
Diabetes Mellitus | 175 (45.4%) | 115 (36.5%) | 0.02 |
Renal Failure | 74 (19.3%) | 55 (17.4%) | 0.50 |
CHF | 38 (10.0%) | 24 (7.6%) | 0.35 |
CAD | 26 (6.9%) | 17 (5.4%) | 0.43 |
Cancer | 48 (12.7%) | 40 (12.7%) | 1.00 |
Admission MELD | 15.6/6.9 | 17.0/7.0 | 0.006 |
Serum Creatinine | 1.43/1.94 | 1.42/1.30 | 0.91 |
Reason for Admission | |||
Hepatology/GI | 318 (83.9%) | 257 (81.3%) | 0.42 |
Renal Failure | 85 (22.4%) | 90 (28.5%) | 0.08 |
Encephalopathy | 151 (39.3%) | 113 (34.9%) | 0.24 |
GI Bleed | 78 (20.5%) | 57 (18.0%) | 1.00 |
Abdominal Pain | 116 (30.7%) | 114 (36.2%) | 0.15 |
Ascites | 246 (64.9%) | 185 (58.5%) | 0.10 |
Independent samples t-test (continuous); Fisher’s Exact (categorical).
CHF: congestive heart failure, CAD: Coronary Artery Disease